Additionally, the immune checkpoint proteins CD80 (B7-1) and CD86 (B7-2) are expressed on the surfaces of both tumor and immune cells, serving as significant prognostic biomarkers in various cancers, including bladder cancer and non-small cell lung carcinoma [24, 25]. This evidence concerns the gene CD86 and neoplasm.